ATE373646T1 - Flavonoidverbindungen als therapeutische antioxidationsmittel - Google Patents

Flavonoidverbindungen als therapeutische antioxidationsmittel

Info

Publication number
ATE373646T1
ATE373646T1 AT03764001T AT03764001T ATE373646T1 AT E373646 T1 ATE373646 T1 AT E373646T1 AT 03764001 T AT03764001 T AT 03764001T AT 03764001 T AT03764001 T AT 03764001T AT E373646 T1 ATE373646 T1 AT E373646T1
Authority
AT
Austria
Prior art keywords
flavonoid compounds
compounds
antioxidants
therapeutic
therapeutic antioxidants
Prior art date
Application number
AT03764001T
Other languages
English (en)
Inventor
Stuart Caldwell
Christopher Bennett
Richard Hartley
Donald Mcphail
Garry Duthie
Original Assignee
Rowett Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rowett Res Inst filed Critical Rowett Res Inst
Application granted granted Critical
Publication of ATE373646T1 publication Critical patent/ATE373646T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/32—2,3-Dihydro derivatives, e.g. flavanones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
AT03764001T 2002-07-13 2003-07-14 Flavonoidverbindungen als therapeutische antioxidationsmittel ATE373646T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0216371.5A GB0216371D0 (en) 2002-07-13 2002-07-13 Compounds

Publications (1)

Publication Number Publication Date
ATE373646T1 true ATE373646T1 (de) 2007-10-15

Family

ID=9940455

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03764001T ATE373646T1 (de) 2002-07-13 2003-07-14 Flavonoidverbindungen als therapeutische antioxidationsmittel

Country Status (9)

Country Link
US (1) US7601754B2 (de)
EP (1) EP1534698B1 (de)
AT (1) ATE373646T1 (de)
AU (1) AU2003251328B2 (de)
CA (1) CA2492274C (de)
DE (1) DE60316447T2 (de)
ES (1) ES2294323T3 (de)
GB (1) GB0216371D0 (de)
WO (1) WO2004007475A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1837202B (zh) * 2006-04-25 2010-08-18 中国人民解放军第二军医大学 具有降血脂作用的黄酮醇类化合物
EP2086318A4 (de) * 2006-10-10 2009-12-23 Burnham Inst Medical Research Neuroprotektive zusammensetzungen und verfahren
GB0623174D0 (en) * 2006-11-21 2006-12-27 Univ Robert Gordon Compounds
US20090092624A1 (en) * 2007-08-17 2009-04-09 Alberte Randall S Antiinfective Flavononol Compounds and Methods of Use Thereof
GB0719751D0 (en) * 2007-10-10 2007-11-21 Antoxis Ltd In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
EP2112145A1 (de) * 2008-04-24 2009-10-28 AxoGlia Therapeutics S.A. Chromenonderivate zur Behandlung von neurodegenerativen Krankheiten
US8034838B2 (en) * 2008-05-29 2011-10-11 Daryl Lee Thompson Composition and method for the treatment of neurological disorders
US20100158829A1 (en) * 2008-12-24 2010-06-24 Conopco, Inc., D/B/A Unilever Method and Composition for Color Modulation
AU2010203223B9 (en) 2009-01-05 2015-10-08 Epitogenesis Inc. Adjuvant compositions and methods of use
GB0906424D0 (en) 2009-04-09 2009-05-20 Antoxis Ltd Use of compounds for differentiation of cells
WO2011029956A1 (en) * 2009-09-14 2011-03-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Flavones and flavanones derivates as dna methyltransferases inhibitors
CN101838252B (zh) * 2010-05-27 2016-05-04 北京德众万全医药科技有限公司 2-正丁基-5-取代氨基苯并呋喃及其制备方法
GB201017315D0 (en) 2010-10-13 2010-11-24 Antoxis Ltd Compound
EP3202398B1 (de) 2011-06-17 2019-12-25 Ludwig Aigner Chroman-ähnliche cyclische prenylflavonoide zur medizinischen intervention bei neurologischen krankheiten
JP6499446B2 (ja) 2011-06-24 2019-04-10 エピットジェネシス・インコーポレーテッド 抗原特異的免疫モジュレーターとして選択担体、ビタミン、タンニンおよびフラボノイドの組み合わせを含有する医薬組成物
US9840488B2 (en) * 2015-01-26 2017-12-12 Utah State University Carbon monoxide releasing molecules and associated methods
US10123991B2 (en) 2015-05-15 2018-11-13 Global Biolife Inc. Electrophilically enhanced phenolic compounds for treating inflammatory related diseases and disorders
CN107382941B (zh) * 2017-07-10 2020-05-08 石家庄学院 黄酮衍生物及其制备方法和应用
KR20190022085A (ko) * 2017-08-25 2019-03-06 건국대학교 글로컬산학협력단 타마리세틴을 유효성분으로 포함하는 패혈증 또는 패혈증성 쇼크의 예방 또는 치료용 약학적 조성물
EP3860984A1 (de) 2018-10-03 2021-08-11 F. Hoffmann-La Roche AG Flavonderivate zur behandlung und prophylaxe von hepatitis-b-virusinfektion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689127B1 (fr) * 1992-03-31 1994-05-06 Adir Cie Nouvelles 3', 5' -ditertbutyl-4'-hydroxy flavones, leur procede de preparation et les compositions pharmaceutiques les renfermant.
EP0743311B1 (de) * 1994-12-02 2002-02-13 Kao Corporation Flavanolderivate und haarnährmittel und sie enthaltende wachstumsfördernde zusammensetzung
GB9521184D0 (en) * 1995-10-17 1995-12-20 Univ Strathclyde Flavonoids

Also Published As

Publication number Publication date
US7601754B2 (en) 2009-10-13
CA2492274A1 (en) 2004-01-22
DE60316447D1 (de) 2007-10-31
US20060137207A1 (en) 2006-06-29
DE60316447T2 (de) 2008-06-26
EP1534698B1 (de) 2007-09-19
AU2003251328B2 (en) 2010-07-15
WO2004007475A1 (en) 2004-01-22
AU2003251328A1 (en) 2004-02-02
GB0216371D0 (en) 2002-08-21
ES2294323T3 (es) 2008-04-01
CA2492274C (en) 2011-06-14
EP1534698A1 (de) 2005-06-01
WO2004007475A8 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
DE60316447D1 (de) Flavonoidverbindungen als therapeutische antioxidationsmittel
BRPI0417723A (pt) composição para melhorar a saúde da pele, cabelo e tegumento contendo flavanonas
TW200512007A (en) Cosmetic compositions containing fullerene clusters
TW200716661A (en) A novel triterpenic acid derivative and the skin external preparation containing the same
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
ATE508116T1 (de) Ionische uv-a-sonnenschutzmittel und zusammensetzungen, die diese enthalten
MY155218A (en) Small molecules useful in the treatment of inflammatory disease
DE59907752D1 (de) Verwendung von erythropoietin oder erythropoietin-derivaten zur behandlung von cerebralen ischämien
DE69826443D1 (de) Antioxidative zusammensetzung
AU3804500A (en) 2-amino-6-anilino-purines and their use as medicaments
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
ATE333263T1 (de) Echinacea-extrakt als antireizendes und alterungsschutzmittel für kosmetika
NZ513096A (en) Compositions for treating inflammatory response
NO975192D0 (no) Bicykliske aromatiske forbindelser
BR0312294A (pt) Arilcarbonil piperazinas e hteroarilcarbonilpiperazinas e o uso das mesmas para tratamento de doenças benignas e malignas
TR200101649T2 (tr) Piperazin türevleri.
ZA200701798B (en) Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalioproteinases inhibitors
EP1178796A4 (de) Aminoimidazolcarboxamidesalze zur vorbeugung und behandlung von leberkrankheiten
DE69703820D1 (de) Diaromatische propynyl- oder dienylverbindungen
TWI691340B (zh) 一種具抗老化、美白、抗過敏及細胞修護之紅藜萃取物
HK1087010A1 (en) Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions
BR0015722A (pt) Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas
MA31505B1 (fr) Hydrogel de carboxyalkylamide de chitosan, sa preparation et son utilisation cosmetique et dermatologique
EA200400436A1 (ru) Медикаменты для профилактики и лечения бромидроза

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1534698

Country of ref document: EP